Research update – ProQR
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
Search results
In February 2022, ProQR announced a disappointing outcome for their phase 2/3 trial of sepofarsen for Leber congenital amaurosis type 10 (LCA10).
With a city centre start and finish, Scotland’s friendliest city always delivers on the support front, with crowds of locals turning out each year to cheer and high-five from beginning to end. Join #TeamRetinaUK this winter!
Our community are the reason we are able to continue supporting those with inherited sight-loss conditions through research and practical support.
Join us for an inspiring webinar where young adults living with sight loss share their extraordinary stories and insights.
During Loneliness Awareness Week, we're hosting a special webinar to address the challenges faced by individuals with sight loss when it comes to travel and mobility.
Fancy fundraising for Retina UK? Here’s a few pointers to help get you started.
Take on a challenge with #TeamRetinaUK and run, jog or walk 10 miles in your neighbourhood whilst raising money for our cause.
In spring 2021, the US company jCyte announced detailed results from their successful phase 2b clinical trial of jCell, a stem cell-based treatment for RP.